[Clinical use of lyophilized sorbitol for the prevention and treatment of postoperative intestinal paresis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D005260:Female; D005612:Freeze Drying; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy* / Q000517:prevention & control*; D051381:Rats; D013012:Sorbitol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D013012:Sorbitol
Klinicheskoe primenenie liofilizirovannogo sorbitola dlia profilaktiki i lecheniia posleoperatsionnogo pareza kishechnika.